Cannabis

Drawing upon the expertise of lawyers across a number of practice areas, Stikeman Elliott delivers innovative legal solutions to cannabis sector clients on a full range of relevant matters. From providing strategic advice on complex acquisitions and regulatory matters to guiding companies doing IPOs and subsequent offerings, Stikeman Elliott is able to leverage its unmatched experience in Canadian business law to assist our clients achieve their objectives in this rapidly expanding sector.

As one of Canada’s most active legal advisors in the sector, we have been at the forefront of the recent wave of cannabis industry transactions. In addition to advising on public and private mergers and acquisitions and other strategic transactions, we have worked on a large number of successful listings on the TSX Venture Exchange, the Toronto Stock Exchange, the Canadian Securities Exchange and the Aequitas NEO Exchange for Canada’s first cannabis-focused SPAC.

Our multidisciplinary team has a deep bench of experience in the life science & healthcare industry and includes lawyers from our Intellectual Property and Employment & Labour practice groups, among others. The team advises on supply agreements, joint venture arrangements, licensing agreements, regulatory matters, intellectual property matters, and other strategic initiatives. Clients include cannabis producers, investors, financiers, advisory firms, underwriters, agents, and pharmaceutical companies in Canada and around the world. This wealth of experience has given us an unparalleled understanding of the industry and enables us to work with clients to manage and minimize risk while achieving their business goals.

Our Expertise

  • Clinical trials
  • Copyright and trademark matters
  • Cross-licensing
  • DINs
  • E-commerce
  • Food and Drugs Act compliance
  • GMP
  • Health Canada approvals and challenges
  • Initial public offerings (IPOs) and go-public transactions
  • Investigations
  • Joint ventures and strategic alliances
  • Labelling and marketing
  • Licensing, manufacturing, wholesale, supply, and distribution agreements
  • Marijuana in the workplace
  • Material transfer agreements
  • Medical marijuana
  • Patent portfolio development
  • Product authorizations, licensing and inspections
  • Product listing agreements
  • Provincial formularies
  • R&D agreements and grants
  • Recalls